Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 151 - 160 of 196 Results.

Intellectual Property Rights for Global Health
John R. Graham | Commentary | Apr. 30, 2015
Dear FDA, Step Aside So We Might Live
Benjamin Powell | Commentary | Apr. 14, 2015
Personalized Medicine: Government Is the Problem, Not the Solution
John C. Goodman | Commentary | Feb. 6, 2015
Relax: The FDA Will Not Regulate Things That Increase the Flow of Your Qi
John R. Graham | Commentary | Feb. 5, 2015
How Can Digital Health Startups Work with Health Insurers and Big Pharma?
John R. Graham | Commentary | Dec. 17, 2014
Hospitals Profit from Drug Discount Program for Poor Americans
John R. Graham | Commentary | Oct. 8, 2014
Save the Children from the FDA
John C. Goodman | Commentary | Oct. 7, 2014
Should You Be Able to Sell Your Kidney?
John C. Goodman | Commentary | Aug. 18, 2014
Can the Exchanges Be Turned into Real Markets?
John C. Goodman | Commentary | July 30, 2014
FDA Meningitis Vaccine Delay Killing Americans
K. Lloyd Billingsley | Commentary | Mar. 12, 2014






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL